Evariant
Company

Last deal

Amount

Series C

Stage

10.05.2016

Date

7

all rounds

$70M

Total amount

General

About Company
Evariant provides healthcare providers with a Patients for Life Platform that helps them acquire and retain patients more efficiently.

Industry

Sector :

Subsector :

founded date

29.10.2008

Operating Status

Closed

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company's SaaS-based enterprise platform uses business intelligence tools, data analysis, and advanced analytics to help leading hospital networks make sense of big data and give marketers and physician relationship teams actionable insights to drive volume and engagement. Evariant is a trusted advisor to over 1000 hospitals nationwide and is committed to helping healthcare providers achieve high-value service line growth, improve provider network utilization and planning, and extend patient lifetime value through its solutions.
Contacts

Phone number

Social url